Skip to main content

Market Overview

Morning Market Gainers

Share:

Onconova Therapeutics Inc (NASDAQ: ONTX) shares jumped 30.99 percent to $1.72. Onconova Therapeutics presented positive data Monday from Phase 2 combination trial of oral Rigosertib And Azacitidine at the ASH 2015.

TherapeuticsMD Inc (NYSEMKT: TXMD) shares gained 30.17 percent to $8.50 after the company reported positive top-line results from its pivotal Phase 3 Rejoice trial of TX-004HR.

Eagle Pharmaceuticals Inc (NASDAQ: EGRX) shares jumped 12.88 percent to $92.47 after the company announced receiving $15 million milestone.

Technical Communications Corporation (NASDAQ: TCCO) shares gained 11.81 percent to $3.69. On Monday, Technical Communications reported a net loss of $(0.64) per share, on revenue of $931,000 for the quarter ended October 3, 2015.

MFRI, Inc. (NASDAQ: MFRI) shares surged 10.82 percent to $6.35. MFRI reported Q3 earnings of $0.83 per share on sales of $66.316 million.

InterCloud Systems Inc (NASDAQ: ICLD) shares gained 8.51 percent to $1.39 after the company reported review of strategic alternatives.

Fairchild Semiconductor Intl Inc (NASDAQ: FCS) shares rose 5.73 percent to $20.65 after the company announced the receipt of an unsolicited bid to be acquired for $21.70 per share in cash.

Ocean Rig UDW Inc (NASDAQ: ORIG) shares surged 4.64 percent to $1.58 after the company reported upbeat Q3 earnings.

FireEye Inc (NASDAQ: FEYE) shares gained 2.63 percent to $20.72. Citigroup upgraded FireEye from Neutral to Buy and raised the price target from $31.00 to $35.00.

 

Related Articles (TXMD + ONTX)

View Comments and Join the Discussion!

Posted-In: Market GainersNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com